Cargando…
A therapeutic Porphyromonas gingivalis gingipain vaccine induces neutralising IgG1 antibodies that protect against experimental periodontitis
Porphyromonas gingivalis infected mice with an established P. gingivalis-specific inflammatory immune response were protected from developing alveolar bone resorption by therapeutic vaccination with a chimera (KAS2-A1) immunogen targeting the major virulence factors of the bacterium, the gingipain p...
Autores principales: | O’Brien-Simpson, Neil M, Holden, James A, Lenzo, Jason C, Tan, Yan, Brammar, Gail C, Walsh, Katrina A, Singleton, William, Orth, Rebecca K H, Slakeski, Nada, Cross, Keith J, Darby, Ivan B, Becher, Dorit, Rowe, Tony, Morelli, Adriana Baz, Hammet, Andrew, Nash, Andrew, Brown, Anna, Ma, Bing, Vingadassalom, Didier, McCluskey, Jacqueline, Kleanthous, Harold, Reynolds, Eric C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707886/ https://www.ncbi.nlm.nih.gov/pubmed/29263860 http://dx.doi.org/10.1038/npjvaccines.2016.22 |
Ejemplares similares
-
Prospects for treatment of Porphyromonas gingivalis-mediated disease – immune-based therapy
por: Reynolds, Eric C., et al.
Publicado: (2015) -
Lipoprotein modifications by gingipains of Porphyromonas gingivalis
por: Lönn, J., et al.
Publicado: (2018) -
Role of Porphyromonas gingivalis gingipains in multi-species biofilm formation
por: Bao, Kai, et al.
Publicado: (2014) -
Proteolytic Activity-Independent Activation of the Immune Response by Gingipains from Porphyromonas gingivalis
por: Ciaston, Izabela, et al.
Publicado: (2022) -
Exopeptidases and gingipains in Porphyromonas gingivalis as prerequisites for its amino acid metabolism
por: Nemoto, Takayuki K., et al.
Publicado: (2016)